Hello, everyone, and how are you today? We hope the weekend was refreshing and relaxing. Now, of course, the routine has resumed. Even if this is an abbreviated week here in the US, there is always much to do, so let the fun begin. You know, meetings, deadlines, reading documents. To ready ourselves, we are indulging in another cup of stimulation and invite you to join us. As always, here are some tidbits to help you along. Hope your day goes well and stay in touch...
Bayer May Have Pitched Yaz And Yasmin For Unapproved Use (Bloomberg News)
Swiss Shareholder Activist Questions Novartis Restructuring (Dow Jones)
CVS Caremark Steers Customers Away From 34 Drugs (Wall Street Journal)
US Army Curbs Use Of Anti-Malaria Drug (Associated Press)
China Wants To Take The Lead In Diabetes Drug (Bloomberg News)
What Drugmakers Spent To Lobby So Far In 2011 (KEI Online)
Valeant Buys Australia's iNova For $623 Million (Reuters)
Pakistani Drugmakers Want To Ban Meds From India (The Express Tribune)
Shire Strikes ADHD Deal With Japan's Shionogi (Pharma Times)
Australia To Review Avastin For Breast Cancer (The Australian)
EDITOR'S NOTE: Please check this post for updates throughout the morning